Thomas Grünewald

49PUBLICATIONS
335CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modellingPredictive and prognostic markersHaematological tumoursSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (49)

|Feb 25, 2026
Targeting replication stress in neuroblastoma by exploiting the synergistic potential of second generation RRM2 and CHK1 inhibitors.

Iris H Nelen, Soetkin Leys, Sarah-Lee Bekaert

|Feb 07, 2026
Author Correction: PHGDH heterogeneity potentiates cancer cell dissemination and metastasis.

Matteo Rossi, Patricia Altea-Manzano, Margherita Demicco

|Jan 03, 2026
Modelling EWS::FLI1 protein fluctuations reveal determinants of tumor plasticity in Ewing sarcoma.

Veveeyan Suresh, Christoph Hafemeister, Andri Konstantinou

|Oct 20, 2025
Cell cycle regulator MYBL2 is a distinct vulnerability in acute myeloid leukemia.

Sandra Küchler, Silke Brilloff, Silvia Schäfer

|Sep 26, 2025
Advancing Preclinical Biology for Ewing Sarcoma: An International Effort.

Filemon S Dela Cruz, Elizabeth A Stewart, Didier Surdez

|Sep 19, 2025
Recurrent and Refractory Ewing Sarcoma Phase I/II Trials: Current Perspective From the Euro-Ewing Consortium.

Antonio Juan Ribelles, Arthur Felix, Nuria Benavent

Pageof 9

Frequent Collaborators

8 joint publications

Florencia Cidre-Aranaz

8 joint publications

Maximilian M L Knott

7 joint publications

James F Amatruda

5 joint publications

Didier Surdez